These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9864894)

  • 1. [Costs of intensive insulin therapy in type 1 diabetes mellitus. Experiences from the DCCT study].
    Szucs TD; Smala AM; Fischer T
    Fortschr Med; 1998 Nov; 116(31):34-8. PubMed ID: 9864894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intensified insulin treatment is cost-effective].
    Reichard P; Alm C; Andersson E; Wärn I; Rosenqvist U
    Lakartidningen; 1999 Jan; 96(3):172-4. PubMed ID: 9951231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive insulin therapy in insulin-dependent diabetes mellitus, the results of the diabetes control and complications trial.
    Duron F
    Biomed Pharmacother; 1995; 49(6):278-82. PubMed ID: 7579008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Nicklasson L; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S67-73. PubMed ID: 15324518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
    Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
    Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of insulin analogs.
    Brixner DI; McAdam-Marx C
    Am J Manag Care; 2008 Nov; 14(11):766-75. PubMed ID: 18999911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of paediatric diabetes care in Germany: current situation and comparison with the year 2000.
    Bächle CC; Holl RW; Straßburger K; Molz E; Chernyak N; Beyer P; Schimmel U; Rütschle H; Seidel J; Lepler R; Holder M; Rosenbauer J; Icks A; ;
    Diabet Med; 2012 Oct; 29(10):1327-34. PubMed ID: 22417295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study.
    Almbrand B; Johannesson M; Sjöstrand B; Malmberg K; Rydén L
    Eur Heart J; 2000 May; 21(9):733-9. PubMed ID: 10739728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study.
    Schöffski O; Breitscheidel L; Benter U; Dippel FW; Müller M; Volk M; Pfohl M
    J Med Econ; 2008; 11(4):695-712. PubMed ID: 19450076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of chronic diabetes complications depending on the method of insulin therapy in children and adolescents with type 1 diabetes].
    Florys B; Ołdytowska A; Głowińska B; Peczyńska J; Urban M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):31-9. PubMed ID: 15355737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
    Schiel R; Müller UA; Braun A; Stein G; Kath R
    Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
    Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
    Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study.
    Liebl A; Breitscheidel L; Nicolay C; Happich M
    Curr Med Res Opin; 2008 Aug; 24(8):2349-58. PubMed ID: 18606055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 diabetes: benefits of intensive insulin therapy. Patients should control blood glucose strictly.
    Prescrire Int; 2002 Apr; 11(58):61. PubMed ID: 11987320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale for glucose control in diabetes mellitus.
    Nathan DM
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):221-35. PubMed ID: 1612066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.